Lumexa Imaging Holdings, Inc. Common Stock (LMRI) Stock Price & Analysis
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) — MoonshotScore 33/100 (Weak band), calculated Nov 18, 2026. Price $14.26 (+1.42%), as of the Nov 20, 2026 trading session; market cap $1.37B.
Educational signal · not a buy or sell recommendation · How to read this
Lumexa Imaging Holdings, Inc. Common Stock · LMRI · NASDAQ
Lumexa Imaging Holdings, Inc. operates diagnostic imaging centers in the United States, providing a range of outpatient medical imaging services. The company offers MRI, CT, PET, X-ray, ultrasound, and mammography services.
Price as of Nov 20, 2026
Key Statistics
MoonshotScore v2 · Lumexa Imaging Holdings, Inc. Common Stock (LMRI)
WeakWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
Durable growth, but a fragile balance sheet. The score also carries a risk penalty for a bankruptcy-risk score in the distress zone and losses on top of negative retained earnings. Business Quality: Solid; Financial Safety: Fragile; Valuation: Fair; Growth Durability: Growing; Momentum: Surging.
- quarterly revenue $272M (Q3 FY2026, quarter ended Sep 30, 2026)
- EPS beat 3 of the last 5 reports
- Altman Z 0.97 · Piotroski F 6
Holding back: balance-sheet strain
Helping: durable growth, positive momentum
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 34 | Weak | |
| 33 | Weak | |
| 33 | Weak | |
| 33 | Weak | |
| 33 | Weak | |
| 33 | Weak |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $14.26 | |
| Change on the day | +1.42% | |
| 52-week range | $6.45 – $19.45 | |
| Market capitalisation | $1.37B | — |
| Shares traded on the day | 442.4K |
Price & events
Other perspectives
Council score for Lumexa Imaging Holdings, Inc. Common Stock (LMRI): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 7, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Apr 29, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Apr 29, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 21, 2026, except a card that shows its own read date.
What is Lumexa Imaging Holdings, Inc. Common Stock (LMRI), and what does it report?
Short answer
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Lumexa Imaging Holdings, Inc. Common Stock (LMRI) is listed on NASDAQ. It employs 5,000 people and is led by Caitlin Zulla. In Q3 FY2026 it reported revenue of $272M and net income of $7M. The market values it at $1.37B.
What do the latest results show for Lumexa Imaging Holdings, Inc. Common Stock (LMRI)?
Short answer · as of
The most recent reported quarter, Q3 FY2026, carried revenue of $272M. Against analyst estimates the company has EPS beat 3 of the last 5 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q3 FY2026 | $272M | $7M | $0.07 (diluted) |
| Q2 FY2026 | $264M | $3M | $0.03 (diluted) |
| Q1 FY2026 | $253M | $2M | $0.02 (diluted) |
| Q4 FY2025 | $268M | -$29M | -$0.38 (diluted) |
What are the financial strengths and risks for Lumexa Imaging Holdings, Inc. Common Stock (LMRI)?
Short answer · as of
The MoonshotScore pillars rate durable growth, positive momentum as strengths. What is holding it back is balance-sheet strain. The distress and quality screens read Altman Z 0.97 · Piotroski F 6. Trailing ratios: ROE -2.8% · ROA -0.9% · current ratio 1.52 · earnings yield -1.2% · free-cash-flow yield 3.8%.
Data-derived red flags
- Financial-distress signal — its Altman Z-Score of 0.97 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-2.8%) — the business is not currently generating profit on shareholder capital.
What should you watch next at Lumexa Imaging Holdings, Inc. Common Stock (LMRI)?
Short answer · as of
The stored analyst-target capture is expired, so a current target watchpoint is unavailable.
What the records here don't tell us
- No forward revenue or earnings estimate is on file.
- The next earnings date is not yet scheduled in the calendar we read.
- No insider Form 4 transaction falls inside the window this page reads.
Checked against the records this page reads, on the dates shown above.
How does Lumexa Imaging Holdings, Inc. Common Stock compare with its peers?
Short answer
Lumexa Imaging Holdings, Inc. Common Stock's score ranks tied for 12th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
| Company | Price | Market value | Score |
|---|---|---|---|
| $55.10 Nov 20, 2026 | $1.60B | 94 5-pillar Nov 18, 2026 | |
| $81.02 Nov 20, 2026 | $1.04B | 94 5-pillar Nov 18, 2026 | |
| $12.42 Nov 20, 2026 | $715M | 92 5-pillar Nov 18, 2026 | |
| $290.85 Nov 20, 2026 | $2.25B | 87 5-pillar Nov 18, 2026 | |
| $46.56 Nov 20, 2026 | $1.39B | 79 5-pillar Nov 18, 2026 | |
| $13.25 Nov 20, 2026 | $1.03B | 68 5-pillar Nov 18, 2026 | |
| $18.10 Nov 20, 2026 | $769M | 62 5-pillar Nov 18, 2026 | |
| $23.73 Nov 20, 2026 | $1.07B | 39 5-pillar Nov 18, 2026 | |
| $31.74 Nov 20, 2026 | $829M | 37 5-pillar Nov 18, 2026 | |
| $69.14 Nov 20, 2026 | $2.06B | 35 5-pillar Nov 18, 2026 | |
| $18.16 Nov 20, 2026 | $886M | 34 5-pillar Nov 18, 2026 | |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI) — this page | $14.26 | $1.37B | 33 |
| $6.12 Nov 20, 2026 | $800M | 33 5-pillar Nov 18, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Last captured analyst target range, low to high (expired, captured Nov 18, 2026)
- $13.00 – $19.00
- Last captured analyst target (expired, captured Nov 18, 2026)
- $16.80
- Last captured median analyst target (expired, captured Nov 18, 2026)
- $18.00
Historical target record · Captured · Capture expired; not a current watchpoint.
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held LMRI in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported LMRI in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Lumexa Imaging Holdings, Inc. Common Stock (LMRI)?
Common Questions About LMRI
These answers are editorial: 1 of these 9 answers is drawn from the LMRI research dossier (written Mar 17, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.
What does the MoonshotScore mean for LMRI?
LMRI carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.
Is LMRI a good stock to buy?
Stock Expert AI does not rate LMRI buy, sell or hold. Lumexa Imaging Holdings, Inc. Common Stock carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the LMRI stock price today?
The last price recorded for Lumexa Imaging Holdings, Inc. Common Stock (LMRI), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the LMRI price target?
The last analyst consensus price target we captured for Lumexa Imaging Holdings, Inc. Common Stock (LMRI), with its FMP capture date, is listed under Analyst targets & estimates on this page. That capture has expired, so read it as historical, not as a current target. Targets are analyst opinions, not a Stock Expert AI forecast.
What does Lumexa Imaging Holdings, Inc. do?
Lumexa Imaging Holdings, Inc. operates a network of diagnostic imaging centers across the United States, providing a comprehensive range of outpatient medical imaging services.
What are the key factors to evaluate for LMRI?
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) holds a MoonshotScore in the low range. Established network of diagnostic imaging centers provides a stable revenue base. Not financial advice.
How frequently does LMRI data refresh on this page?
LMRI's price is the last quote we recorded, from the Nov 20, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven LMRI's recent stock price performance?
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Comprehensive range of imaging services. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider LMRI overvalued or undervalued right now?
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 18 figures on this page — 10 from Financial Modeling Prep (FMP), 7 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com